- Home
- PMVP vs SHLT Comparison
PMVP vs SHLT Comparison
Compare PMVP & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- SHLT
- Stock Information
- Founded
- PMVP 2013
- SHLT 1987
- Country
- PMVP United States
- SHLT Israel
- Employees
- PMVP N/A
- SHLT N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- SHLT Business Services
- Sector
- PMVP Health Care
- SHLT Consumer Discretionary
- Exchange
- PMVP Nasdaq
- SHLT Nasdaq
- Market Cap
- PMVP 85.5M
- SHLT 63.6M
- IPO Year
- PMVP 2020
- SHLT N/A
- Fundamental
- Price
- PMVP $1.65
- SHLT $2.74
- Analyst Decision
- PMVP Strong Buy
- SHLT Strong Buy
- Analyst Count
- PMVP 4
- SHLT 1
- Target Price
- PMVP $5.75
- SHLT $11.00
- AVG Volume (30 Days)
- PMVP 185.0K
- SHLT 3.2K
- Earning Date
- PMVP 11-07-2024
- SHLT 09-26-2024
- Dividend Yield
- PMVP N/A
- SHLT N/A
- EPS Growth
- PMVP N/A
- SHLT N/A
- EPS
- PMVP N/A
- SHLT N/A
- Revenue
- PMVP N/A
- SHLT $55,939,000.00
- Revenue This Year
- PMVP N/A
- SHLT N/A
- Revenue Next Year
- PMVP N/A
- SHLT N/A
- P/E Ratio
- PMVP N/A
- SHLT N/A
- Revenue Growth
- PMVP N/A
- SHLT N/A
- 52 Week Low
- PMVP $1.33
- SHLT $2.60
- 52 Week High
- PMVP $3.47
- SHLT $10.44
- Technical
- Relative Strength Index (RSI)
- PMVP 60.86
- SHLT 37.68
- Support Level
- PMVP $1.63
- SHLT $2.64
- Resistance Level
- PMVP $1.69
- SHLT $2.89
- Average True Range (ATR)
- PMVP 0.07
- SHLT 0.12
- MACD
- PMVP 0.01
- SHLT 0.01
- Stochastic Oscillator
- PMVP 52.65
- SHLT 23.92
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.